Abstract
Dextran-coated superparamagnetic iron oxide nanoparticles (dextran-SPION) have been commercially used for medical applications, such as magnetic imaging or targeted drug delivery, etc. Despite of this usefulness, there are continuous controversies on safety/toxicity of various SPIONs. In the case of dextran-SPION, the reported adverse effects include the cytotoxicity, oxidative stress and DNA damage in many cell types. In this study, the genetic toxicity of dextran-SPION in human hepatoma (HepG2) cells was evaluated with comet assay and cytokinesis-block micronucleus (CBMN) assay. Dextran-SPION did not inhibit cell proliferation as a function of dose and time. The comet assay indicated that 5 μg/mL of dextran-SPION induced a significant DNA strand breaks. A dose-dependent increase of the micronucleus (MN) frequency was observed in CBMN assay. The formation of intracellular reactive oxygen species (ROS) in HepG2 cells was induced by dextran-SPION. The results demonstrated that dextran-SPION exerted genetic toxicity in HepG2 cells. Also, it suggests that a mechanism by which dextran-SPION triggers the DNA and chromosomal damage in HepG2 cells may be via the generation of intracellular ROS.
Similar content being viewed by others
References
Ito, A., Shinkai, M., Honda, H. & Kobayashi, T. Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 100, 1–11 (2005).
Huber, D. L. Synthesis, properties, and applications of iron nanoparticles. Small 1, 482–501 (2005).
Mahmoudi, M., Simchi, A., Milani, A. S. & Stroeve, P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J. Colloid Interface Sci. 336, 510–558 (2009).
Duguet, E., Vasseur, S., Mornet, S. & Devoisselle, J. M. Magnetic nanoparticles and their applications in medicine. Nanomedicine (Lond) 1, 157–168 (2006).
Gupta, A. K. & Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995–4021 (2005).
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B. & Petri-Fink, A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 112, 2323–2338 (2012).
Ayala, A., Muoz, M. F. & Arguelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med. Cell. Longev. 2014, 360438 (2014).
Srinivasan, A., Lehmler, H. J., Robertson, L. W. & Ludewig, G. Production of DNA strand breaks in vitro and reactive oxygen species in vitro and in HL-60 cells by PCB metabolites. Toxicol. Sci. 60, 92–102 (2001).
Wu, H. et al. Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J. Food Drug Anal. 22, 86–94 (2014).
Bulte, J. W. et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141–1147 (2001).
Veranth, J. M. et al. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre. Toxicol. 4, 2 (2007).
Hafeli, U. O. et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 6, 1417–1428 (2009).
Ankamwar, B. et al. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 21, 75102 (2010).
Singh, N. Conference scene -nanotoxicology: health and environmental impacts. Nanomedicine (Lond) 4, 385–390 (2009).
Toyokuni, S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20, 553–566 (1996).
Toyokuni, S. Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep. 7, 189–197 (2002).
Yu, M., Huang, S., Yu, K. J. & Clyne, A. M. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 13, 5554–5570 (2012).
Jha, R. K. et al. An emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnology. Nano Rev. 5, 10.3402/nano.v5.22762 (2014).
Uthaman, S. et al. Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy. BioMed. Res. Int. 2015, 959175 (2015).
Karlsson, H. L., Cronholm, P., Gustafsson, J. & Möller, L. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 21, 1726–1732 (2008).
Mojica Pisciotti, M. L. et al. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. J. Biomed. Mater. Res. B Appl. Biomater. 102, 860–868 (2014).
Singh, N., Jenkins, G. J. S., Asadi, R. & Doak, S. H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1, 10.3402/nano. v1i0.5358 (2010).
Scolastici, C. et al. Antigenotoxicity and antimutagenicity of lycopene in HepG2 cell line evaluated by the comet assay and micronucleus test. Toxicol. in Vitro 22, 510–514 (2008).
Maluf, S. W. Monitoring DNA damage following radiation exposure using cytokinesis-block micronucleus method and alkaline single-cell gel electrophoresis. Clin. Chim. Acta 347, 15–24 (2004).
Valdiglesias, V. et al. Effects of iron oxide nanoparticles: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Environ. Mol. Mutagen. 56, 125–148 (2015).
Remya, N. S., Syama, S., Sabareeswaran, A. & Mohanan, P. V. Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications. Int. J. Pharm. 511, 586–598 (2016).
Könczöl, M. et al. Cytotoxicity and genotoxicity of sizefractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-jB. Chem. Res. Toxicol. 24, 1460–1475 (2011).
Hong, S. C. et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int. J. Nanomedicine 6, 3219–3231 (2011).
Magdolenova, Z. et al. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 9(Suppl 1), 44–56 (2015).
Ma, P. et al. Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int. J. Nanomedicine 7, 4809–4818 (2012).
Mesárošová, M. et al. The role of reactive oxygen species in the genotoxicity of surfacemodified magnetite nanoparticles. Toxicol. Lett. 226, 303–313 (2014).
Kim, S. H. et al. Safety evaluation of zinc oxide nanoparticles in terms of acute dermal toxicity, dermal irritation and corrosion, and skin sensitization. Mol. Cell. Toxicol. 12, 93–99 (2016).
Ying, E. & Hwang, H.-M. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci. Total Environ. 408, 4475–4481 (2010).
Yang, L. et al. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale 7, 625–636 (2015).
Natarajan, A. T. & Darroudi, F. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis 6, 399–403 (1991).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Seo, D.Y., Jin, M., Ryu, JC. et al. Investigation of the genetic toxicity by dextran-coated superparamagnetic iron oxide nanoparticles (SPION) in HepG2 cells using the comet assay and cytokinesis-block micronucleus assay. Toxicol. Environ. Health Sci. 9, 23–29 (2017). https://doi.org/10.1007/s13530-017-0299-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13530-017-0299-z